Propanc Health Group Corp Share Price Other OTC
Equities
US74345C1027
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 559K 46.65M |
---|---|---|---|---|---|
Net income 2022 | -2M -167M | Net income 2023 | -2M -167M | EV / Sales 2022 | - |
Net Debt 2022 | 1.09M 91.4M | Net Debt 2023 | 536K 44.76M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.07
x | P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 15/07/15 | |
Julian Kenyon
FOU | Founder | 77 | 15/07/15 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 15/07/15 | |
Julian Kenyon
FOU | Founder | 77 | 15/07/15 |
Josef Zelinger
BRD | Director/Board Member | 74 | 23/20/23 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |